Bolton Securities’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History
Bought
Maintained
Sold
Other funds holding LABU
Bolton Securities's LABU Position: Q3 2026 in Review
Bolton Securities reduced its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 67% in Q3 2026, selling an estimated $2.78K and leaving 5 shares worth $1.33K. The position accounts for ﹤0.01% of the portfolio, ranked #2142.
Bolton Securities first reported a position in LABU in Q1 2025 and has held it in 7 quarters since. The position peaked at $11.2K in Q3 2025. 38 funds tracked by Wall St. Rank hold LABU as of Q3 2026.
- Bolton Securities held 5 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $1.33K as of Q3 2026.
- Bolton Securities sold 10 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2026, an estimated $2.78K.
- Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Bolton Securities's portfolio in Q3 2026, its #2142 holding.
- Bolton Securities first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2025 and has held it in 7 quarters since.
- Bolton Securities's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $11.2K in Q3 2025.
- 38 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2026.
Based on Bolton Securities's 13F filing for Q3 2026, filed 12 Nov 2026.